INmune Bio Stock Forecast

Stock Price Forecast

The 4 analysts that cover INmune Bio stock have a consensus rating of "Buy" and an average price target of $5.40, which forecasts a 335.48% increase in the stock price over the next year. The lowest target is $0.60 and the highest is $9.00.

Price Target: $5.40 (+335.48%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.60	$5.40	$8.00	$9.00
Change	-51.61%	+335.48%	+545.16%	+625.81%

* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for INmune Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elemer Piros LUCID CAPITAL MARKETS	LUCID CAPITAL MARKETS	Hold → Strong Buy Upgrades $2 → $9	Hold → Strong Buy	Upgrades	$2 → $9	+625.81%	Mar 11, 2026
Ilya Zubkov Freedom Broker	Freedom Broker	Strong Buy Maintains $7 → $4	Strong Buy	Maintains	$7 → $4	+222.58%	Aug 12, 2025
Ilya Zubkov Freedom Broker	Freedom Broker	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+464.52%	Jul 3, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $30 → $8	Strong Buy	Maintains	$30 → $8	+545.16%	Jul 2, 2025
Thomas Shrader BTIG	BTIG	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 50.00K

Revenue Next Year

6.49M

EPS This Year

-0.87

from -1.86

EPS Next Year

-0.90

from -0.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	181.00K	374.00K	155.00K	14.00K	50.00K	-	6.49M
Revenue Growth	1,545.46%	106.63%	-58.56%	-90.97%	257.14%	-	-
EPS	-1.88	-1.52	-1.67	-2.11	-1.86	-0.87	-0.90
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	15.9M
Avg	n/a	6.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.71	-0.54
Avg	-0.87	-0.90
Low	-1.03	-1.07

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.